US Stock MarketDetailed Quotes

MNMD Mind Medicine

Watchlist
  • 8.0400
  • +0.4300+5.65%
Trading Nov 26 10:58 ET
589.59MMarket Cap-4701P/E (TTM)

Mind Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-3.40%-17.19M
-44.38%-19.99M
-24.51%-16.6M
-28.37%-64.37M
-60.04%-20.56M
-78.83%-16.63M
8.47%-13.85M
-3.61%-13.33M
-9.42%-50.14M
-64.04%-12.85M
Net income from continuing operations
23.65%-13.68M
79.90%-5.85M
-119.22%-54.4M
-68.55%-95.73M
-386.72%-23.86M
-8.72%-17.92M
-71.79%-29.13M
-34.49%-24.82M
38.95%-56.8M
70.87%-4.9M
Operating gains losses
-211.74%-8.36M
-1,251.46%-13.45M
544.30%33.41M
196.64%6.27M
132.56%2.6M
---2.68M
--1.17M
--5.19M
---6.49M
---7.99M
Depreciation and amortization
--0
--0
-33.38%527K
-0.57%3.16M
0.00%790K
0.13%791K
-3.66%790K
1.41%791K
21.56%3.18M
0.25%790K
Other non cash items
-24.00%76K
-17,700.00%-2.46M
435.71%75K
265.12%157K
123.08%29K
669.23%100K
--14K
--14K
--43K
--13K
Change In working capital
188.58%1.01M
-136.43%-3.45M
-138.82%-677K
266.08%6.28M
-77.88%-3.8M
-289.98%-1.14M
390.52%9.47M
72.16%1.74M
-301.17%-3.78M
-155.21%-2.13M
-Change in prepaid assets
-12.72%487K
-1,476.85%-1.49M
-48.51%468K
115.00%39K
26.75%-1.54M
-56.94%558K
128.35%108K
-1.41%909K
87.98%-260K
32.14%-2.1M
-Change in payables and accrued expense
146.01%496K
-120.88%-1.97M
-230.92%-1.19M
397.05%7.34M
-922.98%-1.93M
-1,440.00%-1.08M
438.70%9.44M
503.97%912K
-147.54%-2.47M
-97.10%235K
-Change in other current assets
0.00%25K
41.18%24K
266.67%66K
128.33%51K
95.00%-9K
--25K
--17K
--18K
---180K
---180K
-Change in other current liabilities
--0
84.54%-15K
82.11%-17K
-32.41%-1.15M
-244.57%-317K
-2.55%-643K
-6.59%-97K
-58.33%-95K
---870K
---92K
Cash from discontinued investing activities
Operating cash flow
-3.40%-17.19M
-44.38%-19.99M
-24.51%-16.6M
-28.37%-64.37M
-60.04%-20.56M
-78.83%-16.63M
8.47%-13.85M
-3.61%-13.33M
-9.42%-50.14M
-64.04%-12.85M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
298.63%69.35M
746.78%10.79M
28,930.36%169.25M
-63.00%21.85M
523.32%2.59M
-70.11%17.4M
115.93%1.27M
451.20%583K
-40.25%59.05M
227.56%416K
Net issuance payments of debt
--0
--10M
---128K
--14.16M
---42K
--14.2M
--0
--0
--0
--0
Net common stock issuance
2,330.30%75M
--0
30,085.93%175.98M
-82.20%7.53M
254.25%2.59M
-92.58%3.09M
--1.27M
--583K
-48.37%42.3M
--730K
Proceeds from stock option exercised by employees
3,814.91%4.46M
---1.53M
--2.17M
-99.13%163K
--49K
-99.36%114K
--0
--0
10.42%18.66M
--0
Net other financing activities
---10.11M
--2.31M
---8.77M
----
----
----
----
----
---1.91M
---314K
Cash from discontinued financing activities
Financing cash flow
298.63%69.35M
746.78%10.79M
28,930.36%169.25M
-63.00%21.85M
523.32%2.59M
-70.11%17.4M
115.93%1.27M
451.20%583K
-40.25%59.05M
227.56%416K
Net cash flow
Beginning cash position
107.99%243.13M
94.99%252.33M
-29.86%99.7M
6.44%142.14M
-23.83%117.7M
10.55%116.9M
7.42%129.41M
6.44%142.14M
66.73%133.54M
5.89%154.52M
Current changes in cash
6,656.87%52.16M
26.81%-9.2M
1,297.43%152.65M
-577.08%-42.52M
-44.53%-17.97M
-98.42%772K
13.52%-12.57M
2.18%-12.75M
-83.09%8.91M
-63.74%-12.43M
Effect of exchange rate changes
-134.38%-11K
-98.25%1K
-240.00%-21K
125.57%79K
-144.64%-25K
123.53%32K
129.38%57K
142.86%15K
-141.64%-309K
101.17%56K
End cash Position
150.88%295.28M
107.99%243.13M
94.99%252.33M
-29.86%99.7M
-29.86%99.7M
-23.83%117.7M
10.55%116.9M
7.42%129.41M
6.44%142.14M
6.44%142.14M
Free cash flow
-3.40%-17.19M
-44.38%-19.99M
-24.51%-16.6M
-28.37%-64.37M
-60.04%-20.56M
-78.83%-16.63M
8.47%-13.85M
-3.61%-13.33M
-9.42%-50.14M
-64.04%-12.85M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -3.40%-17.19M-44.38%-19.99M-24.51%-16.6M-28.37%-64.37M-60.04%-20.56M-78.83%-16.63M8.47%-13.85M-3.61%-13.33M-9.42%-50.14M-64.04%-12.85M
Net income from continuing operations 23.65%-13.68M79.90%-5.85M-119.22%-54.4M-68.55%-95.73M-386.72%-23.86M-8.72%-17.92M-71.79%-29.13M-34.49%-24.82M38.95%-56.8M70.87%-4.9M
Operating gains losses -211.74%-8.36M-1,251.46%-13.45M544.30%33.41M196.64%6.27M132.56%2.6M---2.68M--1.17M--5.19M---6.49M---7.99M
Depreciation and amortization --0--0-33.38%527K-0.57%3.16M0.00%790K0.13%791K-3.66%790K1.41%791K21.56%3.18M0.25%790K
Other non cash items -24.00%76K-17,700.00%-2.46M435.71%75K265.12%157K123.08%29K669.23%100K--14K--14K--43K--13K
Change In working capital 188.58%1.01M-136.43%-3.45M-138.82%-677K266.08%6.28M-77.88%-3.8M-289.98%-1.14M390.52%9.47M72.16%1.74M-301.17%-3.78M-155.21%-2.13M
-Change in prepaid assets -12.72%487K-1,476.85%-1.49M-48.51%468K115.00%39K26.75%-1.54M-56.94%558K128.35%108K-1.41%909K87.98%-260K32.14%-2.1M
-Change in payables and accrued expense 146.01%496K-120.88%-1.97M-230.92%-1.19M397.05%7.34M-922.98%-1.93M-1,440.00%-1.08M438.70%9.44M503.97%912K-147.54%-2.47M-97.10%235K
-Change in other current assets 0.00%25K41.18%24K266.67%66K128.33%51K95.00%-9K--25K--17K--18K---180K---180K
-Change in other current liabilities --084.54%-15K82.11%-17K-32.41%-1.15M-244.57%-317K-2.55%-643K-6.59%-97K-58.33%-95K---870K---92K
Cash from discontinued investing activities
Operating cash flow -3.40%-17.19M-44.38%-19.99M-24.51%-16.6M-28.37%-64.37M-60.04%-20.56M-78.83%-16.63M8.47%-13.85M-3.61%-13.33M-9.42%-50.14M-64.04%-12.85M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 298.63%69.35M746.78%10.79M28,930.36%169.25M-63.00%21.85M523.32%2.59M-70.11%17.4M115.93%1.27M451.20%583K-40.25%59.05M227.56%416K
Net issuance payments of debt --0--10M---128K--14.16M---42K--14.2M--0--0--0--0
Net common stock issuance 2,330.30%75M--030,085.93%175.98M-82.20%7.53M254.25%2.59M-92.58%3.09M--1.27M--583K-48.37%42.3M--730K
Proceeds from stock option exercised by employees 3,814.91%4.46M---1.53M--2.17M-99.13%163K--49K-99.36%114K--0--010.42%18.66M--0
Net other financing activities ---10.11M--2.31M---8.77M-----------------------1.91M---314K
Cash from discontinued financing activities
Financing cash flow 298.63%69.35M746.78%10.79M28,930.36%169.25M-63.00%21.85M523.32%2.59M-70.11%17.4M115.93%1.27M451.20%583K-40.25%59.05M227.56%416K
Net cash flow
Beginning cash position 107.99%243.13M94.99%252.33M-29.86%99.7M6.44%142.14M-23.83%117.7M10.55%116.9M7.42%129.41M6.44%142.14M66.73%133.54M5.89%154.52M
Current changes in cash 6,656.87%52.16M26.81%-9.2M1,297.43%152.65M-577.08%-42.52M-44.53%-17.97M-98.42%772K13.52%-12.57M2.18%-12.75M-83.09%8.91M-63.74%-12.43M
Effect of exchange rate changes -134.38%-11K-98.25%1K-240.00%-21K125.57%79K-144.64%-25K123.53%32K129.38%57K142.86%15K-141.64%-309K101.17%56K
End cash Position 150.88%295.28M107.99%243.13M94.99%252.33M-29.86%99.7M-29.86%99.7M-23.83%117.7M10.55%116.9M7.42%129.41M6.44%142.14M6.44%142.14M
Free cash flow -3.40%-17.19M-44.38%-19.99M-24.51%-16.6M-28.37%-64.37M-60.04%-20.56M-78.83%-16.63M8.47%-13.85M-3.61%-13.33M-9.42%-50.14M-64.04%-12.85M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data